Back to Results

Beneficient (BENF)

Beneficient is a Nasdaq-listed common equity issued by Beneficient, a technology-enabled financial services company focused on liquidity solutions and related trustee, custody, and trust administration services for participants in the alternative asset industry in the United States. The company operates through three segments: Ben Liquidity, Ben Custody, and Customer ExAlt Trusts. Its Ben AltAccess platform supports online delivery of its products and services, including document upload, task completion, and transaction processing through standardized agreements. Beneficient also provides alternative asset liquidity and fiduciary financing through Ben Liquidity, custody and trust administration through Ben Custody, and broker-dealer and transfer agency services through Ben Markets. Additional activities include Ben Insurance Services and Ben Data, which covers data collection, evaluation, and analytics. The company serves individual and institutional investors, wealth advisors, and general partners, and is based in Dallas, Texas.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-BENF
$1.06
88.7% Upside
Bargain
$9 1,502.0% Upside
Not available
Bargain
Weak
0.0%
November 12, 2026
8.683 M
5.251 M
43.3%
15.2%
-13.4
32.5%
Valuation • Fair Value

Beneficient (NASDAQ-BENF) Fair Value by Valuation Model

Review the available estimates for Beneficient (NASDAQ-BENF), including Comps Fair Value.

Primary Valuation Read

Fair Value

$1.06

Estimated upside of 88.7% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

Comps Fair Value

$1.06

Comparable-company valuation reference.

Analyst Price Target

$9 1,502.0% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use the 4 available valuation references for Beneficient (NASDAQ-BENF) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Beneficient (NASDAQ-BENF)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

-14.337 M

Current operating scale indicator.

Revenue Forecast

59.466 M

Forward revenue estimate.

EBITDA

-50.208 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Beneficient (NASDAQ-BENF) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Beneficient (NASDAQ-BENF)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Altman Z-Score

-13.4

Lower score that deserves closer risk review.

FCF / Net Income

32.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Beneficient (NASDAQ-BENF). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Beneficient (NASDAQ-BENF)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 12, 2026

Days to Earnings

55

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Beneficient (NASDAQ-BENF), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Beneficient (NASDAQ-BENF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Beneficient (NASDAQ-BENF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Beneficient (NASDAQ-BENF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Beneficient (NASDAQ-BENF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Beneficient (NASDAQ-BENF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Beneficient (NASDAQ-BENF) Stock FAQ

Data-supported answers about Beneficient (NASDAQ-BENF), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.06
Estimated upside 88.7%
Valuation Rating
Undervalued
Estimated upside of 88.7%
Analyst Target
$9 1,502.0% Upside
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Beneficient (NASDAQ-BENF) is $1.06. This implies an estimated upside of 88.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 88.7% versus the current market price.

The available analyst price target for Beneficient (NASDAQ-BENF) is $9 1,502.0% Upside.

The current financial health read for Beneficient (NASDAQ-BENF) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Beneficient (NASDAQ-BENF) is November 12, 2026.

The latest available data indicates no current dividend yield for Beneficient (NASDAQ-BENF).

The current market capitalization listed for Beneficient is 8.683 M.

The current enterprise value listed for Beneficient is 5.251 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Beneficient is NASDAQ-BENF, and the stock is listed on NASDAQ.

Beneficient (NASDAQ-BENF) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Beneficient is 43.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Beneficient is 15.2%. Free float helps investors understand how much of the share base is available for public trading.

Similar Capital Markets Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

MS NYSE Morgan Stanley Fair Value Fair Market Cap 318.2 B
MS_PA NYSE Morgan Stanley Pa ADR Fair Value Undervalued Market Cap 318.2 B
MS_PE NYSE Morgan Stanley Pe ADR Fair Value Undervalued Market Cap 318.2 B
MS_PF NYSE Morgan Stanley Pf ADR Fair Value Undervalued Market Cap 318.2 B
MS_PI NYSE Morgan Stanley Pi ADR Fair Value Undervalued Market Cap 318.2 B
GS NYSE Goldman Sachs Group Inc Fair Value Fair Market Cap 285.2 B
SCHW NYSE Charles Schwab Corp Fair Value Undervalued Market Cap 182 B
BLK NYSE BlackRock Inc Fair Value Fair Market Cap 173.7 B
BX NYSE Blackstone Inc Fair Value Undervalued Market Cap 155.6 B
UBS NYSE UBS Group AG Fair Value Fair Market Cap 154.8 B
IBKR NASDAQ Interactive Brokers Group Inc Fair Value Fair Market Cap 151.4 B
SPGI NYSE S&P Global Inc Fair Value Fair Market Cap 119.5 B
HOOD NASDAQ Robinhood Markets Inc Fair Value Overvalued Market Cap 107.7 B
BNY NYSE Bank of New York Mellon Corp Fair Value Fair Market Cap 104.3 B
CME NASDAQ CME Group Inc Fair Value Fair Market Cap 99.24 B
KKR NYSE KKR & Co LP Fair Value Fair Market Cap 88.695 B
ICE NYSE Intercontinental Exchange Inc Fair Value Undervalued Market Cap 87.28 B
BN NYSE Brookfield Corp Fair Value Fair Market Cap 83.795 B
MCO NYSE Moodys Corporation Fair Value Fair Market Cap 81.151 B
BAM NYSE Brookfield Asset Management Inc Fair Value Fair Market Cap 73.598 B